[Nelson's syndrome: course of aggressive pituitary corticotroph adenoma].
Nelson's syndrome was defined in 1958 as the association of an expanding pituitary tumor with high ACTH secretion after bilateral adrenalectomy for Cushing's disease. Pituitary MRI and ACTH measurements led to the definition of Nelson's syndrome as the proliferation of a corticotrophic microadenoma or an aggressive and highly proliferative tumor residue induced by the decreased glucocorticoid inhibition after bilateral adrenalectomy. Now, the problem is not the definition of Nelson's syndrome but rather the identification of markers predictive of tumor growth. Based on a typical case and a review of the literature, we point out some predictive markers of tumor growth after bilateral adrenalectomy: young age at diagnosis, presence of tumor residue on pituitary MRI before adrenalectomy, markers of tumor aggressiveness (Ki-67>3%, mitoses, nuclear PTTG) and increase of ACTH levels during the first months following adrenalectomy.
Mounier
C
C
Service de médecine interne-endocrinologie-diabétologie, hôpital d'instruction des armées Desgenettes, 108, boulevard Pinel, 69003 Lyon cedex, France. chantalmounier@yahoo.fr
Pasquet
F
F
Trouillas
J
J
Perrin
G
G
Jouanneau
E
E
Borson-Chazot
F
F
Colle
B
B
D000236:Adenoma / Q000175:diagnosis / Q000503:physiopathology*; D000324:Adrenocorticotropic Hormone / Q000032:analysis / Q000378:metabolism; D000328:Adult; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009347:Nelson Syndrome / Q000175:diagnosis / Q000503:physiopathology*; D010902:Pituitary Gland / Q000473:pathology; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000503:physiopathology*
D000324:Adrenocorticotropic Hormone